Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 5, 2000, Pages 529-537

  De Andrade, F M ^a   Larrandaburu, M ^a   Callegari Jacques, S M ^a   Gastaldo, G ^b   Hutz, M H ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Alzheimer's disease; APOE; Apoprotein; Lipoproteins; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; DNA; LIPID;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BLOOD; BRAZIL; CASE CONTROL STUDY; CAUCASIAN; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; NEGRO; POLYMERASE CHAIN REACTION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAZIL; CASE-CONTROL STUDIES; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0034181473     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000000500007     Document Type: Article

References (43)

1. Mahley RW (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 240: 622-630.
2. Rubinsztein DC (1995) Apolipoprotein E: a review of its roles in lipoprotein metabolism, neuronal growth and repair as a risk for Alzheimer's disease. Psychological Medicine, 25: 223-229.
3. Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Færgeman O & Dyerberg J (1996). The apolipoprotein E polymorphism in Greenland Inuit in its global perspective Human Genetics, 98: 546-550.
4. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csázȧr A & Utermann G (1991) The apolipoprotein E polymorphism a comparison of allele frequencies and effects in nine populations American Journal of Human Genetics, 49 333-349.
5. Kamboh MI, Aston CE & Hamman RF (1995). The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from San Luis Valley, Colorado, Atherosclerosis, 112: 145-159.
6. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois A, Cheung V, Onat H, Fulks P, Mahley L, Vakar F, Osbayrak S, Gökdemir O & Winkler W (1995) Turkish Heart Study: lipids, lipoproteins, and apolipoproteins Journal of Lipid Research, 36: 839-859.
7. Boer JMA, Feskens EJM, Schouten EG, Havekes LM, Seidell JC & Kromhout D (1998). Lipid profiles reflecting high and low risk for coronary heart disease: contribution of apolipoprotein E polymorphism and lifestyle Atherosclerosis, 136: 395-402.
8. Tiret L, De Knijff P, Menzel H, Ehnholm C, Nicaud V & Havekes LM (1994). ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations - The EARS study, Arteriosclerosis and Thrombosis, 14 1617-1624.
9. Moore JH, Reilly SL, Ferrel RE & Sing CF (1997). The role of the apolipoprotein E polymorphism in the prediction of coronary artery disease age of onset Clinical Genetics, 51: 22-25.
10. Strittmatter WJ, Saunders AM & Schmechel D (1993) Apolipoprotein E: High affinity binding to ßA amyloid and increased frequency of type 4 allele in familial Alzheimer's disease Proceedings of the National Academy of Sciences, USA, 90: 1977-1981.
11. Lendon CL, Ashall F & Goate AM (1997) Exploring the etiology of Alzheimer's disease using molecular genetics Journal of the American Medical Association, 277: 825-831.
12. McKhann G, Drachman D, Folstein M, Katzmar R, Price D & Stadlan EM (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Departments of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34: 939-944.
13. Chamberlain JC, Thorn JA, Oka K, Galton DJ & Stocks J (1989). DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis, 79: 85-91.
14. Lahin DK & Nurnberger JI (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research, 19: 5444.
15. Maekawa B, Cole TG, Seip RL & Bylund D (1995) Apolipoprotein E genotyping methods for the clinical laboratory. Journal of Clinical Laboratory Analysis, 9: 63-69.
16. 2 and the problem of small samples. Molecular Biology and Evolution, 6: 539-545.
17. Templeton AR (1987). The general relationship between average effect and average excess Genetics Research, 49: 69-70.
18. Gerdes LU, Klausen IC, Sihm I & Færgeman O (1992). Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Generic Epidemiology, 9: 155-167.
19. Knijff P de, Maagdenberg AMJM, Frants RR & Havekes LM (1994). Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Human Mutation, 4: 178-194.
20. Valveny N, Esteban E, Kandil M & Moral P (1997). APO E polymorphism in Spanish and Moroccan populations. Clinical Genetics, 51: 354-356.
21. Lucotte G, Loirat F & Hazout S (1997). Pattern of gradient of apolipoprotein E allele *4 frequencies in Western Europe Human Biology, 69: 253-262.
22. Corbo RM, Scacchi R, Mureddu L, Mulas G & Alfano G (1995). Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique. Comparison with frequency data of other European populations. Annals of Human Genetics, 59: 197-209.
23. Sepehrnia B, Kamboh MI, Adams-Campbell LL, Bunker CH, Nwankwo M, Majumder PP & Ferrell RE (1989). Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. American Journal of Human Genetics, 45: 586-591.
24. Zekraoui L, Lagarde JP, Raisonnier A, Gérard N, Aouizérate A & Lucotte G (1997). High frequency of the apolipoprotein E*4 allele in African Pygmies and most of African populations in Sub-Saharan Africa. Human Biology, 69: 575-581.
25. Bortolini MC, Silva Jr WA, Guerra DC, Remonatto G, Mirandola R, Hutz MH, Weimer TA, Silva MCBO, Zago MA & Salzano FM (1999). African-derived South American populations: a history of symmetrical and asymmetrical matings according to sex revealed by bi- and uniparental genetic markers, American Journal of Human Biology, 11: 551-563.
26. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-McLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D & Roses AD (1993). Association of apolipoprotein E allele E*4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43: 1467-1472.
27. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N & Van Dujin CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease - A meta-analysis Journal of the American Medical Association, 278: 1349-1356.
28. Kervinen K, Savolainen MJ, Salokannel J, Hynninen A, Heikkinen J, Ehnholm C, Koistinen MJ & Kesäniemi YA (1994). Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians. Atherosclerosis, 105: 89-95.
29. Louhija J, Miettinen HE, Kontula K, Tikkanen MJ, Miettinen TA & Tilvis RS (1994) Aging and genetic variation of plasma apolipoproteins - Relative loss of the apolipoprotein E4 phenotype in centenarians. Arteriosclerosis and Thrombosis, 14: 1084-1089.
30. Haviland MB, Lussier-Cacan S, Davignon J & Sing CF (1995). Impact of apolipoprotein E genotype variation on means, variances, and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenarians. American Journal of Medical Genetics, 58: 315-331.
31. Corder EH, Lannfelt L, Viitanen M, Corder LS, Manton KG, Winbiad B & Basun H (1996). Apolipoprotein E genotype determnes survival in the oldest old (85 years or older) who have good cognition. Archives of Neurology, 53: 418-422.
32. Pablos-Méndez A, Mayeux R, Ngai C, Shea S & Berglund L (1997). Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arteriosclerosis, Thrombosis, and Vascular Biology, 17: 3534-3541.
33. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM & Davignon J (1991). Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arteriosclerosis and Thrombosis, 11: 1100-1110.
34. Zaman MM, Ikemoto S, Yoshiike N, Date C, Yokoyama T & Tanaka H (1997) Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. Arteriosclerosis, Thrombosis, and Vascular Biology, 17: 3495-3504.
35. Boer JMA, Ehnholm C, Menzel H, Havekes LM, Rosseneu M, O'Reilly DSJ & Tiret L (1997). Interactions between life-style-related factors and the apoE polymorphism on plasma lipids and apolipoproteins - The EARS study. Arteriosclerosis, Thrombosis, and Vascular Biology, 17: 1675-1681.
36. Bohnet K, Regis-Bailly A, Vincent-Viry M, Schlenck A, Gueguen R, Siest G & Visvikis S (1996) Apolipoprotein E genotype E*4/ E*2 in the STANISLAS Cohort Study - Dominance of the E*2 allele? Annals of Human Genetics, 60: 509-516.
37. Sandholzer C, Delport R, Vermaak H & Utermann G (1995). High frequency of the apo E4 allele in Khoi San from South Africa. Human Genetics, 95: 46-48.
38. Robitaille N, Cormier G, Couture R, Bouthillier D, Davignon J & Pérusse L (1996). Apolipoprotein E polymorphism in a French Canadian population of north-eastern Quebec: allele frequencies and effects on blood lipid and lipoprotein levels. Human Biology, 68: 357-370.
39. Valdez R, Stern MP, Howard BV & Haffner SM (1995). Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care, 18: 992-1000.
40. Muros M & Rodriguez-Ferrer C (1996). Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis, 121: 13-21.
41. Gregg RE, Zech LA, Schaefer EJ & Brewer Jr HB (1981). Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. Science, 211: 584-586.
42. Ghiselli G, Schaefer EJ, Zech LA, Gregg RE & Brewer Jr HB (1982). Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia. Journal of Clinical Investigation, 70: 474-477.
43. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP & Wilson PWF (1994). Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Arteriosclerosis and Thrombosis, 14: 1105-1113.